Select Page

Drug Safety: Current overview of FDA postmarket surveillance

How can we better execute postmarket drug surveillance?  A recent study proposes formation of a detailed, publicly available database that could be continually updated and aggregated with new information as new clinical study results are published. how does ivermectin...

Drug Safety: FDA’s Postmarket Decision-making Process

This US Government Accountability Office’s (GAO) current report (2007) gives a brief history and overview of the 2 FDA branches – Office of New Drugs (OND), and the Office of Drug Safety (ODS) –  mandated to oversee postmarketed drug safety. لعبة...